1. Home
  2. TRVI vs PLGO Comparison

TRVI vs PLGO Comparison

Compare TRVI & PLGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

SELL

Current Price

$13.31

Market Cap

1.9B

Sector

Health Care

ML Signal

SELL

Logo Pelagos Insurance Capital Limited Common Shares

PLGO

Pelagos Insurance Capital Limited Common Shares

SELL

Current Price

$28.58

Market Cap

2.0B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
TRVI
PLGO
Founded
2011
2014
Country
United States
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
TRVI
PLGO
Price
$13.31
$28.58
Analyst Decision
Strong Buy
Hold
Analyst Count
11
9
Target Price
★ $28.18
$26.94
AVG Volume (30 Days)
★ 1.5M
374.2K
Earning Date
11-09-2026
11-11-2026
Dividend Yield
N/A
★ 3.06%
EPS Growth
★ 31.91
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$5.49
Revenue Next Year
N/A
$5.68
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.82
$20.85
52 Week High
$20.22
$29.70

Technical Indicators

Market Signals
Indicator
TRVI
PLGO
Relative Strength Index (RSI) 46.10 67.91
Support Level $13.00 $23.95
Resistance Level $13.55 N/A
Average True Range (ATR) 0.88 0.76
MACD 0.06 0.15
Stochastic Oscillator 20.92 71.02

Price Performance

Historical Comparison
TRVI
PLGO

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

About PLGO Pelagos Insurance Capital Limited Common Shares

Pelagos Insurance Capital Ltd operates in the specialty insurance and reinsurance sector. Its activities include capital allocation, risk selection, and the deployment of capital through underwriting partnerships across insurance and reinsurance markets. The company manages a diversified portfolio and works with underwriting partners to provide insurance and reinsurance solutions to clients and brokers.

Share on Social Networks: